NO326216B1 - Et universalt anvendelig blodplasma og fremgangsmate for fremstilling derav. - Google Patents

Et universalt anvendelig blodplasma og fremgangsmate for fremstilling derav. Download PDF

Info

Publication number: NO326216B1
Authority: NO; Norway
Prior art keywords: blood; plasma; blood plasma; type; donors
Prior art date: 1997-08-05

Application number

NO20000578A

Other languages

English (en)

Norwegian (no)

Other versions

NO20000578L (no

NO20000578D0 (no

Inventor

Wolfgang Marguerre

Tor-Einar Svae

Original Assignee

Octapharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-05

Filing date

2000-02-04

Publication date

2008-10-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO326216(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-02-04 Application filed by Octapharma Ag filed Critical Octapharma Ag

2000-02-04 Publication of NO20000578D0 publication Critical patent/NO20000578D0/no

2000-03-27 Publication of NO20000578L publication Critical patent/NO20000578L/no

2008-10-20 Publication of NO326216B1 publication Critical patent/NO326216B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Developmental Biology & Embryology (AREA)
Immunology (AREA)
Virology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
External Artificial Organs (AREA)
Prostheses (AREA)

NO20000578A 1997-08-05 2000-02-04 Et universalt anvendelig blodplasma og fremgangsmate for fremstilling derav. NO326216B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97113466A EP0896824A1 (en)	1997-08-05	1997-08-05	A universally applicable blood plasma
PCT/EP1998/004841 WO1999007390A1 (en)	1997-08-05	1998-08-04	A universally applicable blood plasma

Publications (3)

Publication Number	Publication Date
NO20000578D0 NO20000578D0 (no)	2000-02-04
NO20000578L NO20000578L (no)	2000-03-27
NO326216B1 true NO326216B1 (no)	2008-10-20

Family

ID=8227172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000578A NO326216B1 (no)	1997-08-05	2000-02-04	Et universalt anvendelig blodplasma og fremgangsmate for fremstilling derav.

Country Status (25)

Country	Link
US (1)	US20110008459A1 (sh)
EP (2)	EP0896824A1 (sh)
JP (1)	JP2001513507A (sh)
CN (1)	CN1272061A (sh)
AT (1)	ATE225665T1 (sh)
AU (1)	AU742427B2 (sh)
BG (1)	BG64350B1 (sh)
BR (1)	BR9811839A (sh)
CA (1)	CA2299421C (sh)
CZ (1)	CZ293726B6 (sh)
DE (1)	DE69808620T3 (sh)
DK (1)	DK0991416T4 (sh)
EA (1)	EA003182B1 (sh)
ES (1)	ES2185218T5 (sh)
HK (1)	HK1026146A1 (sh)
HU (1)	HU226548B1 (sh)
ID (1)	ID24308A (sh)
IL (1)	IL134308A (sh)
NO (1)	NO326216B1 (sh)
NZ (1)	NZ502661A (sh)
PL (1)	PL193983B1 (sh)
PT (1)	PT991416E (sh)
RS (1)	RS50016B (sh)
TW (1)	TW555563B (sh)
WO (1)	WO1999007390A1 (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6214221B1 (en) *	1999-02-22	2001-04-10	Henry B. Kopf	Method and apparatus for purification of biological substances
CN1207004C (zh) *	2001-04-18	2005-06-22	马建川	通用型冻干血浆及其制备方法
US20070071829A1 (en) *	2003-12-19	2007-03-29	Andrea Heger	Universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma
EP1958618A1 (de)	2007-02-15	2008-08-20	Octapharma AG	Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
US9867782B2 (en) *	2009-04-09	2018-01-16	Entegrion, Inc.	Spray-dried blood products and methods of making same
US8407912B2 (en)	2010-09-16	2013-04-02	Velico Medical, Inc.	Spray dried human plasma
WO2011035062A2 (en)	2009-09-16	2011-03-24	Velico Medical, Inc.	Spray dried human plasma
FR2963737B1 (fr) *	2010-08-16	2013-04-05	Etat Francais Ministere De La Defense Service De Sante Des Armees	Procede de lyophilisation de plasma sanguin
US8533971B2 (en)	2010-10-29	2013-09-17	Velico Medical, Inc.	System and method for spray drying a liquid
US20140083628A1 (en)	2012-09-27	2014-03-27	Velico Medical, Inc.	Spray drier assembly for automated spray drying
US9561184B2 (en)	2014-09-19	2017-02-07	Velico Medical, Inc.	Methods and systems for multi-stage drying of plasma
FR3026950A1 (fr)	2014-10-09	2016-04-15	Lab Francais Du Fractionnement	Procede de preparation de plasma universel
FR3035794B1 (fr)	2015-05-06	2017-05-05	Elicityl	Procede pour la purification du sang total ou d'un produit issu du sang
FR3035799B1 (fr)	2015-05-06	2017-05-05	Elicityl	Support pour la purification de liquides biologiques
US10793327B2 (en)	2017-10-09	2020-10-06	Terumo Bct Biotechnologies, Llc	Lyophilization container and method of using same
FR3083121B1 (fr)	2018-06-27	2021-10-22	Maco Pharma Sa	Procede de greffage d un element fibreux pour l elimination d anticorps du sang ou d un composant sanguin
CA3130670A1 (en)	2019-03-14	2020-09-17	Terumo Bct Biotechnologies, Llc	Lyophilization loading tray assembly and system
DE102020212609B3 (de) *	2020-10-06	2022-04-07	Universität Greifswald	Verfahren und Vorrichtung zur Herstellung von Universalplasma
US11975274B2 (en)	2022-09-15	2024-05-07	Velico Medical, Inc.	Blood plasma product
US11998861B2 (en)	2022-09-15	2024-06-04	Velico Medical, Inc.	Usability of a disposable for a spray drying plasma system
US12246266B2 (en)	2022-09-15	2025-03-11	Velico Medical, Inc.	Disposable for a spray drying system
US12083447B2 (en)	2022-09-15	2024-09-10	Velico Medical, Inc.	Alignment of a disposable for a spray drying plasma system
US11841189B1 (en)	2022-09-15	2023-12-12	Velico Medical, Inc.	Disposable for a spray drying system
US12246093B2 (en)	2022-09-15	2025-03-11	Velico Medical, Inc.	Methods for making spray dried plasma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4664913A (en) *	1982-05-24	1987-05-12	Xoma Corporation	Method for treating plasma for transfusion
US4764369A (en) *	1983-07-14	1988-08-16	New York Blood Center Inc.	Undenatured virus-free biologically active protein derivatives
US4551435A (en) *	1983-08-24	1985-11-05	Immunicon, Inc.	Selective removal of immunospecifically recognizable substances from solution
JPH0723319B2 (ja) *	1986-05-14	1995-03-15	株式会社ミドリ十字	血液製剤から血液型抗体を除去する方法
DE4008852A1 (de) †	1990-03-20	1991-09-26	Octapharma Ag	Verfahren zur herstellung von nicht-infektioesem blutplasma
US5217627A (en) *	1990-11-06	1993-06-08	Pall Corporation	System and method for processing biological fluid
JP3575770B2 (ja) *	1992-03-31	2004-10-13	学校法人藤田学園	血漿由来製剤
AU667530B2 (en) *	1992-05-28	1996-03-28	New York Blood Center, Inc., The	Removal of antibodies from blood-derived compositions while retaining coagulation factors

1997
- 1997-08-05 EP EP97113466A patent/EP0896824A1/en not_active Withdrawn
1998
- 1998-02-19 TW TW087102313A patent/TW555563B/zh not_active IP Right Cessation
- 1998-08-04 NZ NZ502661A patent/NZ502661A/xx not_active IP Right Cessation
- 1998-08-04 CN CN98809602A patent/CN1272061A/zh active Pending
- 1998-08-04 AT AT98945141T patent/ATE225665T1/de active
- 1998-08-04 CA CA002299421A patent/CA2299421C/en not_active Expired - Fee Related
- 1998-08-04 DE DE69808620T patent/DE69808620T3/de not_active Expired - Lifetime
- 1998-08-04 ID IDW20000224A patent/ID24308A/id unknown
- 1998-08-04 PT PT98945141T patent/PT991416E/pt unknown
- 1998-08-04 JP JP2000506980A patent/JP2001513507A/ja active Pending
- 1998-08-04 BR BR9811839-0A patent/BR9811839A/pt not_active Application Discontinuation
- 1998-08-04 CZ CZ2000370A patent/CZ293726B6/cs not_active IP Right Cessation
- 1998-08-04 ES ES98945141T patent/ES2185218T5/es not_active Expired - Lifetime
- 1998-08-04 WO PCT/EP1998/004841 patent/WO1999007390A1/en active IP Right Grant
- 1998-08-04 RS YUP-58/00A patent/RS50016B/sr unknown
- 1998-08-04 DK DK98945141T patent/DK0991416T4/da active
- 1998-08-04 PL PL98338794A patent/PL193983B1/pl not_active IP Right Cessation
- 1998-08-04 EP EP98945141A patent/EP0991416B2/en not_active Expired - Lifetime
- 1998-08-04 HU HU0004795A patent/HU226548B1/hu not_active IP Right Cessation
- 1998-08-04 EA EA200000196A patent/EA003182B1/ru not_active IP Right Cessation
- 1998-08-04 AU AU92569/98A patent/AU742427B2/en not_active Ceased
- 1998-08-04 IL IL13430898A patent/IL134308A/en not_active IP Right Cessation
2000
- 2000-02-01 BG BG104117A patent/BG64350B1/bg unknown
- 2000-02-04 NO NO20000578A patent/NO326216B1/no not_active IP Right Cessation
- 2000-08-31 HK HK00105463A patent/HK1026146A1/xx not_active IP Right Cessation
2010
- 2010-09-17 US US12/923,380 patent/US20110008459A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO1999007390A1 (en)	1999-02-18
NO20000578L (no)	2000-03-27
ID24308A (id)	2000-07-13
ATE225665T1 (de)	2002-10-15
RS50016B (sr)	2008-09-29
EP0896824A1 (en)	1999-02-17
ES2185218T3 (es)	2003-04-16
ES2185218T5 (es)	2008-04-16
BG104117A (en)	2000-12-29
EP0991416B2 (en)	2007-10-31
CA2299421C (en)	2009-11-10
HUP0004795A2 (hu)	2001-04-28
JP2001513507A (ja)	2001-09-04
AU742427B2 (en)	2002-01-03
EA003182B1 (ru)	2003-02-27
EA200000196A1 (ru)	2000-10-30
BG64350B1 (bg)	2004-11-30
BR9811839A (pt)	2000-08-15
TW555563B (en)	2003-10-01
YU5800A (sh)	2003-02-28
NO20000578D0 (no)	2000-02-04
IL134308A0 (en)	2001-04-30
HK1026146A1 (en)	2000-12-08
HUP0004795A3 (en)	2003-08-28
PT991416E (pt)	2003-02-28
CN1272061A (zh)	2000-11-01
DK0991416T3 (da)	2003-02-10
AU9256998A (en)	1999-03-01
DE69808620D1 (de)	2002-11-14
US20110008459A1 (en)	2011-01-13
PL193983B1 (pl)	2007-04-30
DK0991416T4 (da)	2008-02-25
IL134308A (en)	2004-09-27
NZ502661A (en)	2001-03-30
DE69808620T2 (de)	2003-06-26
EP0991416A1 (en)	2000-04-12
EP0991416B1 (en)	2002-10-09
CZ293726B6 (cs)	2004-07-14
CA2299421A1 (en)	1999-02-18
PL338794A1 (en)	2000-11-20
HU226548B1 (en)	2009-03-30
CZ2000370A3 (cs)	2000-09-13
DE69808620T3 (de)	2008-05-21

Publication	Publication Date	Title
NO326216B1 (no)	2008-10-20	Et universalt anvendelig blodplasma og fremgangsmate for fremstilling derav.
US20090092678A1 (en)	2009-04-09	Universally applicable blood plasma
KR0162094B1 (ko)	1998-12-01	혈소판 막 미립자
US12133868B2 (en)	2024-11-05	Viral inactivated biological mixture
KR20200015440A (ko)	2020-02-12	혈소판 분비물질을 함유하는 성장 인자들을 마련하는 방법
HRP931496A2 (en)	1996-10-31	Process for the preparation of biological preparations not containing (active) viruses
TW201207113A (en)	2012-02-16	Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
JPH09124507A (ja)	1997-05-13	ウイルスを不活化した静脈内注射可能な免疫血清グロブリンの調製
US20110104298A1 (en)	2011-05-05	Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma
US4770877A (en)	1988-09-13	Isolation of a high molecular weight aortic endothelial cell growth inhibitor
Oberman et al.	1966	Erythrocyte sensitization and anemia due to isoantibodies in lyophilized pooled plasma
MXPA00001259A (en)	2001-11-21	A universally applicable blood plasma
Dzik	2000	Aprotinin and transfusion requirements in orthotopic liver transplantation: A multicenter randomized double-blind study: RJ Porte, IQ Molenaar, B. Begliomini, et al. Lancet 355: 1303–1309, 2000
Colvin et al.	1986	Heat‐treated NHS factor VIII concentrate in the United Kingdom—a preliminary study
Ockelford et al.	1987	Controlled pore glass Factor VIII concentrate: influence of heat treatment
CS270021B1 (cs)	1990-06-13	2působ přípravy nízkomolekulárnlch látek obsahujících imunomodulační aktivity z buněčných lyzátů lidských a zvířecích tkání, vylučující přítomnost infekčních agens a jejich toxických produktů
CZ386991A3 (en)	1993-08-11	combined process for preparing blood plasma free of infectious germs

Legal Events

Date	Code	Title	Description
2013-03-25	MM1K	Lapsed by not paying the annual fees